---
title: "Orthofix surges after CMS change on non-invasive bone growth stimulators"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291821968.md"
description: "Orthofix Medical shares surged 16% after the Centers for Medicare & Medicaid Services (CMS) reversed its decision to reclassify non-invasive bone growth stimulators. Analysts noted that this reversal allows Orthofix to expect reimbursement rates to return to prior levels, though future assessments remain possible."
datetime: "2026-07-06T15:15:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291821968.md)
  - [en](https://longbridge.com/en/news/291821968.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291821968.md)
generator: "portal-rs"
---

# Orthofix surges after CMS change on non-invasive bone growth stimulators


### Related Stocks

- [OFIX.US](https://longbridge.com/en/quote/OFIX.US.md)

## Related News & Research

- [Orthofix President, Global Limb Recon Patrick Fisher sells 150 shares for $1,408.5](https://longbridge.com/en/news/297957106.md)
- [Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook](https://longbridge.com/en/news/296010681.md)
- [Syra Health, in Partnership with HealthSync, Selected for CMS ACCESS Model, Advancing Long-Term Growth Strategy | SYRA Stock News](https://longbridge.com/en/news/297909428.md)
- [CMS: Aggressive clean energy expansion and $24B capital plan drive 6–8% EPS growth outlook](https://longbridge.com/en/news/297955344.md)
- [What Pennant Group (PNTG)'s Raised Revenue Guidance and Q2 Beat Mean For Shareholders](https://longbridge.com/en/news/298114753.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**